Skip to the content
  • Our Company
    • Management Team
    • Board Members
    • Events
  • Our Approach
  • Partner
  • Careers
  • Resources
  • News
Menu
  • Our Company
    • Management Team
    • Board Members
    • Events
  • Our Approach
  • Partner
  • Careers
  • Resources
  • News
  • Contact
Menu
  • Contact
Our Company

>

Deval A. Lashkari, PhD

Deval A. Lashkari, PhD

Director

Deval has more than 20 years of experience helping to build and grow successful companies. He is currently a partner at Telegraph Hill Partner and serves on several boards. Prior to THP he was a founding Research Director at Synteni, which was acquired by Incyte Genomics.

Deval received a BA from the University of California, Berkeley and a PhD from Stanford University and currently serves on the Stanford Medical School Alumni Board of Governors.

LinkedIn
PreviousDan Zabrowski, PhD
NextPaul D. Grossman, PhD
PreviousDan Zabrowski, PhD
NextPaul D. Grossman, PhD

Where You Can Find Us

No event found!
No event found!
View full calendar of events
  • Our Company
  • Our Approach
  • Partner
  • Careers
  • Resources
  • Contact
Menu
  • Our Company
  • Our Approach
  • Partner
  • Careers
  • Resources
  • Contact
Copyright © 2023 Nimble Therapeutics, Inc
  • Our Company
  • Our Approach
  • Partner
  • Careers
  • Resources
  • Contact
  • Our Company
  • Our Approach
  • Partner
  • Careers
  • Resources
  • Contact
  • Our Company
  • Our Approach
  • Partner
  • Careers
  • Resources
  • Contact
  • Our Company
  • Our Approach
  • Partner
  • Careers
  • Resources
  • Contact

603 Science Dr
Madison, WI, USA 53711

LinkedIn
  • Nimble Therapeutics Announces Expansion of its Discovery and Development Partnership with Genentech
    Read More